arrow
J

Joaquím Gascón

is-global
H指数:64
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials

量化抗锥虫治疗在慢性不确定型恰加斯病中的效果:一项来自两项概念验证试验的个体患者数据的二次分析

2025-09-090
OAAI
A guide for the generation of repositories of clinical samples for research on Chagas disease
2024-08-151
OAAI
A standardized clinical database for research in Chagas disease: The NHEPACHA network
2024-08-152
OAAI
Malaria and other infections induce polyreactive antibodies that impact SARS-CoV-2 seropositivity estimations in endemic settings
2024-06-140
OAAI
Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial
2024-04-0115
PRE
Five-year serological and clinical evolution of chronic Chagas disease patients in Cochabamba, Bolivia
2023-12-290
OAAI
Characterization of Latin American migrants at risk for Trypanosoma cruzi infection in a non-endemic setting. Insights into initial evaluation of cardiac and digestive involvement
2023-07-134
OAAI
Usefulness of Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry in the Characterization of Leishmania Strains Causing Tegumentary Leishmaniasis in Bolivia versus hsp70 Gene Sequencing

基质辅助激光解吸/电离飞行时间质谱在表征玻利维亚与hsp70基因测序引起的利什曼原虫菌株中的作用

2023-02-142
OAAI
Clinical profile and mortality in patients with T. cruzi/HIV co-infection from the multicenter data base of the Network for healthcare and study of Trypanosoma cruzi/HIV co-infection and other immunosuppression conditions (vol 15, e0009809, 2021)
2023-01-041
OAAI
A Branched and Double Alpha-Gal-Bearing Synthetic Neoglycoprotein as a Biomarker for Chagas Disease

一种带有分支和双 α-gal的合成新糖蛋白作为查加斯病的生物标志物

2022-09-053
OAAI